Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:AQSNYSE:EVENYSE:HVTCVE:LBL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAQSAequus PharmaceuticalsC$0.01-37.5%C$0.01C$0.01▼C$0.04C$663K-0.02162,442 shs100,000 shsEVEEVe Mobility Acquisition$11.27$11.27$10.63▼$12.03$175.77MN/A25,790 shsN/AHVTHaverty Furniture Companies$21.06+9.8%$19.50$17.01▼$30.13$340.18M1.41196,335 shs192,165 shsLBLLattice BiologicsC$0.04C$0.04C$0.03▼C$0.13C$5.13MN/A468,022 shs114,000 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAQSAequus Pharmaceuticals0.00%0.00%0.00%0.00%-75.00%EVEEVe Mobility Acquisition0.00%0.00%0.00%0.00%+2.41%HVTHaverty Furniture Companies0.00%-5.09%+6.18%-12.64%-32.70%LBLLattice Biologics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAQSAequus PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AEVEEVe Mobility AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AHVTHaverty Furniture Companies2.8563 of 5 stars0.01.01.73.02.51.73.1LBLLattice BiologicsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAQSAequus Pharmaceuticals 0.00N/AN/AN/AEVEEVe Mobility Acquisition 3.00Buy$5.00-55.62% DownsideHVTHaverty Furniture Companies 2.00HoldN/AN/ALBLLattice Biologics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HVT, LBL, AQS, and EVE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025HVTHaverty Furniture CompaniesSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAQSAequus PharmaceuticalsC$1.17M0.57C$0.00 per share5.00C($0.04) per share-0.13EVEEVe Mobility AcquisitionN/AN/AN/AN/AN/AN/AHVTHaverty Furniture Companies$720.47M0.47$4.52 per share4.66$19.10 per share1.10LBLLattice BiologicsC$1.56M3.29N/AN/AC$0.00 per share40.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAQSAequus Pharmaceuticals-C$2.86M-C$0.01N/A∞N/AN/A-1,569.60%-178.79%N/AEVEEVe Mobility AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AHVTHaverty Furniture Companies$56.32M$1.2613.2513.411.153.57%8.69%4.12%7/30/2025 (Estimated)LBLLattice BiologicsN/A-C$0.01N/A∞N/AN/AN/AN/AN/ALatest HVT, LBL, AQS, and EVE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025HVTHaverty Furniture Companies$0.14$0.23+$0.09$0.23$178.36 million$181.60 million2/24/2025Q4 2024HVTHaverty Furniture Companies$0.17$0.47+$0.30$0.47$179.84 million$184.35 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAQSAequus PharmaceuticalsN/AN/AN/AN/AN/AEVEEVe Mobility AcquisitionN/AN/AN/AN/AN/AHVTHaverty Furniture Companies$1.286.08%+9.11%101.59%4 YearsLBLLattice BiologicsN/AN/AN/AN/AN/ALatest HVT, LBL, AQS, and EVE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/19/2025HVTHaverty Furniture Companiesquarterly$0.326%3/6/20253/6/20253/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAQSAequus Pharmaceuticals138.880.070.46EVEEVe Mobility AcquisitionN/AN/AN/AHVTHaverty Furniture CompaniesN/A1.821.17LBLLattice BiologicsN/A0.020.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAQSAequus PharmaceuticalsN/AEVEEVe Mobility AcquisitionN/AHVTHaverty Furniture Companies80.57%LBLLattice BiologicsN/AInsider OwnershipCompanyInsider OwnershipAQSAequus Pharmaceuticals14.68%EVEEVe Mobility Acquisition57.70%HVTHaverty Furniture Companies8.63%LBLLattice BiologicsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAQSAequus Pharmaceuticals12132.63 millionN/ANot OptionableEVEEVe Mobility Acquisition415.60 million6.60 millionNot OptionableHVTHaverty Furniture Companies2,84016.15 million14.95 millionOptionableLBLLattice BiologicsN/A128.22 millionN/ANot OptionableHVT, LBL, AQS, and EVE HeadlinesRecent News About These CompaniesVC Aditum Bio hatches autoimmune-focused Oblenio Bio with asset from Chinese biotechNovember 8, 2024 | fiercebiotech.comBest Lattice Alternatives Of 2024September 17, 2024 | forbes.comIVBIY Innovent Biologics, Inc.January 10, 2024 | seekingalpha.comMagnetic lattice surpriseOctober 28, 2023 | nature.comAbCellera Biologics GAAP EPS of -$0.14, revenue of $12MMay 7, 2023 | seekingalpha.comLattice USB IP CoreApril 25, 2023 | design-reuse.comADMA Biologics Stock (NASDAQ:ADMA), Analyst Ratings, Price Targets, PredictionsMarch 28, 2023 | benzinga.comThree Part Deep Dive Explains Lattice ICE40 FPGA DetailsMarch 20, 2023 | hackaday.comLattice Biologics Ltd (LBLh)March 2, 2023 | investing.comLattice Announces Lattice Connect Partner Ecosystem to Help Organizations Maximize People SuccessSeptember 23, 2022 | markets.businessinsider.comField Architecture clads Silicon Valley synagogue in salvaged-wood latticeSeptember 12, 2022 | dezeen.comLattice Semiconductor Corp LSCC Stock QuoteSeptember 9, 2022 | morningstar.comNotice of Lattice Biologics Ltd. Year End 2016 Financial Results Conference CallOctober 26, 2021 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumGold Rally Continues: These 3 Mining Stocks Are Likely to BenefitBy Chris Markoch | April 16, 2025View Gold Rally Continues: These 3 Mining Stocks Are Likely to Benefit2 Smart Investments to Follow Warren Buffett’s LeadBy Ryan Hasson | April 23, 2025View 2 Smart Investments to Follow Warren Buffett’s LeadAST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockBy Jea Yu | April 21, 2025View AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockHVT, LBL, AQS, and EVE Company DescriptionsAequus Pharmaceuticals CVE:AQSC$0.0050 0.00 (-37.50%) As of 04/25/2025Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.EVe Mobility Acquisition NYSE:EVE$11.27 0.00 (0.00%) As of 05/9/2025EVe Mobility Acquisition Corp does not have significant operations. The company focuses on effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on the automotive and mobility industry. The company was incorporated in 2021 and is based in Wilmington, Delaware.Haverty Furniture Companies NYSE:HVT$21.06 +1.88 (+9.80%) Closing price 03:59 PM EasternExtended Trading$21.00 -0.06 (-0.28%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Haverty Furniture Companies, Inc. operates as a specialty retailer of residential furniture and accessories in the United States. The company offers furniture merchandise under the Havertys brand name. It also provides custom upholstery products and eclectic looks; and mattress product lines under the Tempur-Pedic, Serta, Sealy, and Stearns and Foster names. The company sells home furnishings through its retail stores, as well as through its website. Haverty Furniture Companies, Inc. was founded in 1885 and is headquartered in Atlanta, Georgia.Lattice Biologics CVE:LBLC$0.04 0.00 (0.00%) As of 06/3/2021Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
